870837-19-7Relevant articles and documents
SALTS OF CYNNAMIDE COMPOUND OR SOLVATES THEREOF
-
Page/Page column 14, (2008/12/07)
The invention provides crystals of dihydrochloride monohydrate of the compound of the following formula having an Aβ production inhibiting effect which crystals are characterized by exhibiting a diffraction peak at an angle of diffraction (2θ ± 0.2°) of 10.9° in powder X-ray diffractometry. Further, the invention also provides the compound in the form of various salts, crystal forms and amorphous forms which are suitable for the development of drugs.
Therapeutic agent for Abeta related disorders
-
Page/Page column 29, (2010/11/24)
The present invention provides a pharmaceutical composition comprising at least one member selected from a compound capable of enhancing Aβ37 production, a compound capable of inhibiting Aβ40 and Aβ42 production and enhancing Aβ37 production, and salts of